Abstract:To review our current knowledge of the pathologic bone metabolism in otosclerosis and to discuss the possibilities of non-surgical, pharmacological intervention. Otosclerosis has been suspected to be associated with defective measles virus infection, local inflammation and consecutive bone deterioration in the human otic capsule. In the early stages of otosclerosis, different pharmacological agents may delay the progression or prevent further deterioration of the disease and consecutive hearing loss. Although effective anti-osteoporotic drugs have become available, the use of sodium fluoride and bisphosphonates in otosclerosis has not yet been successful. Bioflavonoids may relieve tinnitus due to otosclerosis, but there is no data available on long-term application and effects on sensorineural hearing loss. In the initial inflammatory phase, corticosteroids or non-steroidal anti-inflammatory drugs may be effective; however, extended systemic application may lead to serious side effects. Vitamin D administration may have effects on the pathological bone loss, as well as on inflammation. No information has been reported on the use of immunosuppressive drugs. Anti-cytokine targeted biological therapy, however, may be feasible. Indeed, one study on the local administration of infliximab has been reported. Potential targets of future therapy may include osteoprotegerin, RANK ligand, cathepsins and also the Wnt-β-catenin pathway. Finally, anti-measles vaccination may delay the progression of the disease and potentially decrease the number of new cases. In conclusion, stapes surgery remains to be widely accepted treatment of conductive hearing loss due to otosclerosis. Due to lack of solid evidence, the place of pharmacological treatment targeting inflammation and bone metabolism needs to be determined by future studies.

Participation of central regulating mechanisms in otosclerosis pathogenesis (literature review)

Current research in otosclerosis

The pathophysiology of otosclerosis: Review of current research

Etiopathogenetic aspects of otosclerosis

An overview of the etiology of otosclerosis

The aetiology of otosclerosis: a review of the literature

[Pathogenetic aspects of otosclerosis]

An introduction of genetics in otosclerosis: a systematic review

Otosclerosis and Measles: Do Measles Have a Role in Otosclerosis? A Review Article

The genetics of otosclerosis

Molecular biology of otosclerosis

The etiology of otosclerosis: a combination of genes and environment

Otosclerosis: From Genetics to Molecular Biology

The genetics of otosclerosis: pedigree studies and linkage analysis

Advances in the Study of Etiology and Molecular Mechanisms of Sensorineural Hearing Loss

Revisiting the Cochlear and Central Mechanisms of Tinnitus and Therapeutic Approaches

Potential role of modulating autophagy levels in sensorineural hearing loss

Otosclerosis. Histopathology, light and electron microscopy

The Putative Role of Measles Virus in the Pathogenesis of Otosclerosis

[Physiopathology of otosclerosis. Preliminary research]

Perspectives of pharmacological treatment in otosclerosis